RESUMEN
Background: Electrical stimulation therapy (EST) has been shown to be an effective therapy for managing pressure ulcers in individuals with spinal cord injury (SCI). However, there is a lack of uptake of this therapy, and it is often not considered as a first-line treatment, particularly in the community. Objective: To develop a pressure ulcer model of care that is adapted to the local context by understanding the perceived barriers and facilitators to implementing EST, and to describe key initial phases of the implementation process. Method: Guided by the Knowledge-to-Action (KTA) and National Implementation Research Network (NIRN) frameworks, a community-based participatory research (CBPR) approach was used to complete key initial implementation processes including (a) defining the practice, (b) identifying the barriers and facilitators to EST implementation and organizing them into implementation drivers, and (c) developing a model of care that is adapted to the local environment. Results: A model of care for healing pressure ulcers with EST was developed for the local environment while taking into account key implementation barriers including lack of interdisciplinary collaboration and communication amongst providers between and across settings, inadequate training and education, and lack of resources, such as funding, time, and staff. Conclusions: Using established implementation science frameworks with structured planning and engaging local stakeholders are important exploratory steps to achieve a successful sustainable best practice implementation project.
Asunto(s)
Investigación Participativa Basada en la Comunidad , Terapia por Estimulación Eléctrica , Úlcera por Presión/terapia , Traumatismos de la Médula Espinal/complicaciones , Comunicación , Humanos , Úlcera por Presión/etiologíaRESUMEN
UNLABELLED: In this cross-sectional study, we found that areal bone mineral density (aBMD) at the knee and specific tibia bone geometry variables are associated with fragility fractures in men and women with chronic spinal cord injury (SCI). INTRODUCTION: Low aBMD of the hip and knee regions have been associated with fractures among individuals with chronic motor complete SCI; however, it is unclear whether these variables can be used to identify those at risk of fracture. In this cross-sectional study, we examined whether BMD and geometry measures are associated with lower extremity fragility fractures in individuals with chronic SCI. METHODS: Adults with chronic [duration of injury ≥ 2 years] traumatic SCI (C1-L1 American Spinal Cord Injury Association Impairment Scale A-D) reported post injury lower extremity fragility fractures. Dual-energy X-ray absorptiometry (DXA) was used to measure aBMD of the hip, distal femur, and proximal tibia regions, while bone geometry at the tibia was assessed using peripheral quantitative computed tomography (pQCT). Logistic regression and univariate analyses were used to identify whether clinical characteristics or bone geometry variables were associated with fractures. RESULTS: Seventy individuals with SCI [mean age (standard deviation [SD]), 48.8 (11.5); 20 females] reported 19 fragility fractures. Individuals without fractures had significantly greater aBMD of the hip and knee regions and indices of bone geometry. Every SD decrease in aBMD of the distal femur and proximal tibia, trabecular volumetric bone mineral density, and polar moment of inertia was associated with fracture prevalence after adjusting for motor complete injury (odds ratio ranged from 3.2 to 6.1). CONCLUSION: Low knee aBMD and suboptimal bone geometry are significantly associated with fractures. Prospective studies are necessary to confirm the bone parameters reported to predict fracture risk in individuals with low bone mass and chronic SCI.
Asunto(s)
Fracturas Osteoporóticas/etiología , Traumatismos de la Médula Espinal/complicaciones , Absorciometría de Fotón/métodos , Adulto , Densidad Ósea/fisiología , Estudios Transversales , Femenino , Fémur/fisiopatología , Articulación de la Cadera/fisiopatología , Humanos , Articulación de la Rodilla/fisiopatología , Extremidad Inferior/lesiones , Masculino , Persona de Mediana Edad , Fracturas Osteoporóticas/fisiopatología , Medición de Riesgo/métodos , Factores de Riesgo , Traumatismos de la Médula Espinal/fisiopatología , Tibia/fisiopatologíaRESUMEN
O artigo não apresenta resumo.
RESUMEN
Esta pesquisa avaliou a interferência da dexametasona no processo de reparo ósseo em ferida cirúrgica, produzida na tíbia de rato. A amostragem dos animais foi dividida em três grupos. Em todos os grupos, foram produzidas duas perfurações monocorticais na diáfise da tíbia. O material foi coletado e processado para análise histológica, nos períodos de 24 a 48 horas, 7 e 21 dias, após a fase cirúrgica. O grupo controle não recebeu injeção intramuscular de dexametasona. outro grupo de animais recebeu 1 hora antes do procedimento cirúrgico uma dose de 0,1ml. de solução contendo 8mg de dexametasona por 5ml de soro fisiológico. O terceiro grupo recebeu 1 hora antes de cirurgia e continuou recebendo a mesma dose durante os 3 dias posteriores, em um intervalo de 8 em 8 horas. Análises histólogicas comparativas dos processos reparativos mostrara, no grupo controle e no grupo que rcebeu apenas uma dose pré-ciruúrgica que o reparo das perfurações foi determinado aos 21 dias. No grupo que recebeu pré-cirúrgica e continuou recebendo a dose durante o período experimental, houve evidente atraso no processo reparativo. Aos 21 dias pós-cirurgico, ainda foi possível observar um tecido de granulação, entremeado por blastemas ósseos. Remanescentes do coágulo foram observados e o periósteo não foi completamente reparado. Estas observções demonstram um nítido atraso no processo cicatricial, o que deverá ser considerado no momento da prescrição de antiinflamatórios esteroidais quando se deseja somente a diminuição do edema facial
Asunto(s)
Animales , Ratas , Tibia , Dexametasona , Mantenimiento CorrectivoRESUMEN
The RXR serves as a heterodimer partner for the PPARgamma and the dimer is a molecular target for insulin sensitizers such as the thiazolidinediones. Ligands for either receptor can activate PPAR-dependent pathways via PPAR response elements. Unlike PPARgamma agonists, however, RXR agonists like LG100268 are promiscuous and activate multiple RXR heterodimers. Here, we demonstrate that LG100754, a RXR:RXR antagonist and RXR:PPARalpha agonist, also functions as a RXR:PPARgamma agonist. It does not activate other LG100268 responsive heterodimers like RXR:liver X receptoralpha, RXR:liver X receptorbeta, RXR:bile acid receptor/farnesoid X receptor and RXR:nerve growth factor induced gene B. This unique RXR ligand triggers cellular RXR:PPARgamma-dependent pathways including adipocyte differentiation and inhibition of TNFalpha-mediated hypophosphorylation of the insulin receptor, but does not activate key farnesoid X receptor and liver X receptor target genes. Also, LG100754 treatment of db/db animals leads to an improvement in insulin resistance in vivo. Interestingly, activation of RXR:PPARgamma by LG100268 and LG100754 occurs through different mechanisms. Therefore, LG100754 represents a novel class of insulin sensitizers that functions through RXR but exhibits greater heterodimer selectivity compared with LG100268. These results establish an approach to the design of novel RXR-based insulin sensitizers with greater specificity.
Asunto(s)
Glucemia/metabolismo , Receptores Citoplasmáticos y Nucleares/agonistas , Receptores de Ácido Retinoico/agonistas , Retinoides/farmacología , Tetrahidronaftalenos/farmacología , Factores de Transcripción/agonistas , Células 3T3 , Adipocitos/efectos de los fármacos , Adipocitos/metabolismo , Animales , Diferenciación Celular/efectos de los fármacos , Diabetes Mellitus/sangre , Diabetes Mellitus/tratamiento farmacológico , Dimerización , Resistencia a la Insulina , Ratones , Ácidos Nicotínicos/farmacología , Fosforilación , Receptor de Insulina/metabolismo , Receptores Citoplasmáticos y Nucleares/efectos de los fármacos , Receptores Citoplasmáticos y Nucleares/fisiología , Receptores de Ácido Retinoico/efectos de los fármacos , Receptores de Ácido Retinoico/fisiología , Receptores X Retinoide , Retinoides/uso terapéutico , Tetrahidronaftalenos/uso terapéutico , Factores de Transcripción/efectos de los fármacos , Factores de Transcripción/fisiología , Factor de Necrosis Tumoral alfa/farmacologíaRESUMEN
Methemoglobinemia is an uncommon but important complication associated with the use of topical anesthetics. We describe four cases of methemoglobinemia induced by topical benzocaine use. We review pathophysiology, early diagnosis, and therapy for this reversible yet potentially fatal condition. Physicians who use procedures involving the application of topical anesthetics need to be aware of this side effect to prevent significant morbidity and mortality.
Asunto(s)
Anestésicos Locales/efectos adversos , Benzocaína/efectos adversos , Metahemoglobinemia/inducido químicamente , Anciano , Humanos , Masculino , Persona de Mediana EdadRESUMEN
Cytomegalovirus ventriculoencephalitis (CMV-VE) is a devastating opportunistic infection seen most frequently in patients with AIDS. The authors describe eight patients with AIDS and CMV-VE, who developed the clinical features of the Wernicke-Korsakoff syndrome, including impaired memory, confabulation, nystagmus, ophthalmoplegia, and ataxia. CMV-VE is perhaps a more frequent cause of the Wernicke-Korsakoff syndrome than traditional associations.
Asunto(s)
Infecciones Oportunistas Relacionadas con el SIDA/fisiopatología , Infecciones por Citomegalovirus/fisiopatología , Encefalitis Viral/fisiopatología , Encefalopatía de Wernicke/fisiopatología , Adulto , Sistema Nervioso Central/fisiopatología , Humanos , MasculinoRESUMEN
Steroidogenic factor 1 (SF-1), an orphan nuclear receptor, initially was isolated as a key regulator of the tissue-specific expression of the cytochrome P450 steroid hydroxylases. Thereafter, analyses of sites of SF-1 expression during mouse embryological development hinted at considerably expanded roles for SF-1, roles that were strikingly confirmed through the analyses of SF-1 knockout mice. These SF-1 knockout mice exhibited adrenal and gonadal agenesis, associated with male-to-female sex reversal of their internal and external genitalia and death from adrenocortical insufficiency. These findings showed unequivocally that SF-1 is essential for the embryonic survival of the primary steroidogenic organs. SF-1 knockout mice also had impaired pituitary expression of gonadotropins and agenesis of the ventromedial hypothalamic nucleus (VMH), establishing that SF-1 regulates reproductive function at all three levels of the hypothalamic-pituitary gonadal axis. This article reviews the experiments that have defined these essential roles of SF-1 in endocrine development and highlights important areas for future studies.
Asunto(s)
Proteínas de Unión al ADN/fisiología , Glándulas Endocrinas/embriología , Glándulas Endocrinas/fisiología , Factores de Transcripción/fisiología , Animales , Femenino , Factores de Transcripción Fushi Tarazu , Proteínas de Homeodominio , Masculino , Ratones , Ratones Noqueados , Receptores Citoplasmáticos y Nucleares , Factor Esteroidogénico 1RESUMEN
The nuclear receptor SF1 is an essential mediator in ventromedial hypothalamus-pituitary-gonadal development. As with other nuclear receptors, SF1 possesses a DNA-binding domain composed of two zinc fingers and a ligand-binding domain containing a ligand-dependent activation sequence termed AF2. To dissect the domain function of SF1, we examined various SF1 mutants in mouse adrenocortical Y1 cells and human placental JEG3 cells. Destruction of the AF2 structure removed 73-90% transactivation activity, suggesting that AF2 is indispensable for transactivation. Mutants carrying the DNA-binding domain but lacking the AF2 or the ligand-binding domain blocked the activity of normal SF1. Disrupting the zinc finger diminished the dominant negative effect of mutant. Cotransfection of SF1 with AP1 showed that the two transcription factors cooperated to activate gene expression. Some mutants lost the synergistic action with AP1, while some retained partial activity. These experiments delineate the functional domains of SF1.
Asunto(s)
Proteínas de Unión al ADN/genética , Peroxidasas , Factores de Transcripción/genética , Animales , Sitios de Unión/genética , Línea Celular , Proteínas de Unión al ADN/metabolismo , Factores de Transcripción Fushi Tarazu , Gónadas/embriología , Gónadas/fisiología , Proteínas de Homeodominio , Humanos , Hipotálamo/embriología , Hipotálamo/fisiología , Ratones , Mutación , Peroxirredoxinas , Hipófisis/embriología , Hipófisis/fisiología , Receptores Citoplasmáticos y Nucleares , Factor Esteroidogénico 1 , Hormonas Tiroideas/metabolismo , Factores de Transcripción/metabolismo , Dedos de ZincRESUMEN
Steroidogenic factor 1 (SF-1), an orphan member of the intracellular receptor superfamily, plays an essential role in the development and function of multiple endocrine organs. It is expressed in all steroidogenic tissues where it regulates the P450 steroidogenic genes to generate physiologically active steroids. Although many of the functions of SF-1 in vivo have been defined, an unresolved question is whether a ligand modulates its transcriptional activity. Here, we show that 25-, 26-, or 27-hydroxycholesterol, known suppressors of cholesterol biosynthesis, enhance SF-1-dependent transcriptional activity. This activation is dependent upon the SF-1 activation function domain, and, is specific for SF-1 as several other receptors do not respond to these molecules. The oxysterols activate at concentrations comparable to those previously shown to inhibit cholesterol biosynthesis, and, can be derived from cholesterol by P450c27, an enzyme expressed within steroidogenic tissues. Recent studies have shown that the nuclear receptor LXR also is activated by oxysterols. We demonstrate that different oxysterols differ in their rank order potency for these two receptors, with 25-hydroxycholesterol preferentially activating SF-1 and 22(R)-hydroxycholesterol preferentially activating LXR. These results suggest that specific oxysterols may mediate transcriptional activation via different intracellular receptors. Finally, ligand-dependent transactivation of SF-1 by oxysterols may play an important role in enhancing steroidogenesis in vivo.
Asunto(s)
Proteínas de Unión al ADN/fisiología , Hidroxicolesteroles/farmacología , Factores de Transcripción/fisiología , Transcripción Genética/efectos de los fármacos , Secuencia de Aminoácidos , Animales , Sitios de Unión , Línea Celular , Chlorocebus aethiops , Proteínas de Unión al ADN/biosíntesis , Proteínas de Unión al ADN/efectos de los fármacos , Factores de Transcripción Fushi Tarazu , Proteínas Fluorescentes Verdes , Proteínas de Homeodominio , Humanos , Cinética , Proteínas Luminiscentes/biosíntesis , Datos de Secuencia Molecular , Receptores Citoplasmáticos y Nucleares/biosíntesis , Receptores Citoplasmáticos y Nucleares/efectos de los fármacos , Receptores Citoplasmáticos y Nucleares/fisiología , Receptores de Hormona Tiroidea/fisiología , Proteínas Recombinantes de Fusión/metabolismo , Homología de Secuencia de Aminoácido , Factor Esteroidogénico 1 , Factores de Transcripción/biosíntesis , Factores de Transcripción/efectos de los fármacos , TransfecciónRESUMEN
Retinoid X receptor (RXR) plays a central role in the regulation of many intracellular receptor signalling pathways and can mediate ligand-dependent transcription, acting as a homodimer or as a heterodimer. Here we identify an antagonist towards RXR homodimers which also functions as an agonist when RXR is paired as a heterodimer to specific partners, including peroxisome proliferator-activated receptor and retinoic acid receptor. This dimer-selective ligand confers differential interactions on the transcription machinery: the antagonist promotes association with TAF110 (TATA-binding protein (TBP)-associated factor 110) and the co-repressor SMRT, but not with TBP, and these properties are distinct from pure RXR agonists. This unique class of RXR ligands will provide a means to control distinct target genes at the level of transcription and allow the development of retinoids with a new pharmacological action.
Asunto(s)
Proteínas de Drosophila , Ácidos Nicotínicos/farmacología , Receptores de Ácido Retinoico/metabolismo , Retinoides/farmacología , Factores Asociados con la Proteína de Unión a TATA , Tetrahidronaftalenos/farmacología , Factor de Transcripción TFIID , Factores de Transcripción/metabolismo , Proteínas de Unión al ADN/metabolismo , Dimerización , Regulación de la Expresión Génica , Ligandos , Co-Represor 2 de Receptor Nuclear , Receptores Citoplasmáticos y Nucleares/metabolismo , Receptores de Ácido Retinoico/agonistas , Receptores de Ácido Retinoico/antagonistas & inhibidores , Receptores de Ácido Retinoico/química , Proteínas Represoras/metabolismo , Receptores X Retinoide , Retinoides/metabolismo , Proteína de Unión a TATA-Box , Transactivadores/metabolismo , Factores de Transcripción/agonistas , Factores de Transcripción/antagonistas & inhibidores , Factores de Transcripción/química , Transcripción Genética/fisiología , Transfección , Células Tumorales CultivadasRESUMEN
Expression of the gene encoding the mitochondrial fatty acid. beta-oxidation enzyme, medium-chain acyl-CoA dehydrogenase (MCAD), is regulated among tissues during development and in response to alterations in substrate availability. To identify and characterize cis-acting MCAD gene promoter regulatory elements and corresponding transcription factors, DNA-protein binding studies and mammalian cell transfection analyses were performed with hjman MCAD gene promoter fragments. DNA:protein binding studies with nuclear protein extracts prepared from hepatoma G2 cells, 3T3 fibroblasts, or Y-1 adrenal tumor cells identified three sequences (nuclear receptor response element 1 or NRRE-1, NRRE-2, and NRRE-3) that bind orphan members of the steroid/thyroid nuclear receptor superfamily including chicken ovalbumin upstream promoter transcription factor and steroidogenic factor 1. Sp1 binding sites (A-C) were identified in close proximity to each of the NRREs. NRRE-3 conferred cell line-specific transcriptional repression by interacting with chicken ovalbumin upstream promoter transcription factor or activation via steroidogenic factor 1. In contrast, the Sp1 binding site A behaved as a transcriptional activator in all cell lines examined. We propose that multiple nuclear receptor transcription factors interact with MCAD gene promoter elements to differentially regulate transcription among a variety of cell types.
Asunto(s)
Acil-CoA Deshidrogenasas/genética , Mitocondrias/enzimología , Regiones Promotoras Genéticas/genética , Receptores Citoplasmáticos y Nucleares/metabolismo , Factor de Transcripción Sp1/metabolismo , Células 3T3 , Acil-CoA Deshidrogenasa , Animales , Secuencia de Bases , Sitios de Unión , Pollos , ADN Recombinante/metabolismo , Regulación de la Expresión Génica , Humanos , Ratones , Datos de Secuencia Molecular , Ovalbúmina/genética , Unión Proteica , Receptores de Esteroides/metabolismo , Receptores de Hormona Tiroidea/metabolismo , Factor Esteroidogénico 1 , Transcripción Genética , TransfecciónRESUMEN
Recent analyses of the cytochrome P450 steroid hydroxylases have established a key role for an orphan nuclear receptor, designated steroidogenic factor 1 (SF-1), in their coordinate, cell-selective expression. SF-1 was proposed to regulate the steroid hydroxylases by interacting with shared promoter elements in their 5'-flanking regions. During mouse embryonic development, SF-1 was expressed from the earliest stages of organogenesis of the steroidogenic tissues, suggesting a key role in steroidogenic cell differentiation. Finally, disruption of the gene encoding SF-1 revealed its essential function in the development of the adrenal glands and gonads and in pituitary gonadotrope function. These studies suggest that SF-1 acts at multiple levels of the reproductive axis to maintain reproductive competence.
Asunto(s)
Glándulas Suprarrenales/embriología , Proteínas de Unión al ADN/fisiología , Drosophila/embriología , Genes de Insecto , Gónadas/embriología , Factores de Transcripción/fisiología , Animales , Diferenciación Celular/fisiología , Proteínas de Drosophila , Embrión no Mamífero/fisiología , Desarrollo Embrionario y Fetal/fisiología , Factores de Transcripción Fushi Tarazu , Proteínas de Homeodominio , Sistema Hipotálamo-Hipofisario/fisiología , Proteínas de Insectos , Masculino , Ratones , Ratones Noqueados , Receptores Citoplasmáticos y Nucleares , Factor Esteroidogénico 1RESUMEN
Recent studies of the gene regulation of the cytochrome P450 steroid hydroxylases have established a key role for an orphan nuclear receptor, designated steroidogenic factor 1 (SF-1). SF-1 binds to shared promoter elements upstream of the steroid hydroxylases to mediate their coordinate expression in steroidogenic cells. Analyses of SF-1 expression during mouse embryonic development showed that SF-1 is expressed from the earliest stages of organogenesis of the steroidogenic tissues, suggesting an intimate link between SF-1 and steroidogenic cell differentiation. Finally, in gene disruption experiments, the gene encoding SF-1 was shown to be essential for development of the adrenal glands and gonads. These results establish the essential role of this orphan nuclear receptor in the development and function of the primary steroidogenic tissues.
Asunto(s)
Proteínas de Unión al ADN/fisiología , Receptores Citoplasmáticos y Nucleares/fisiología , Esteroide Hidroxilasas/metabolismo , Factores de Transcripción , Glándulas Suprarrenales/embriología , Animales , Factores de Transcripción Fushi Tarazu , Regulación del Desarrollo de la Expresión Génica/fisiología , Gónadas/embriología , Proteínas de Homeodominio , Ratones , Factor Esteroidogénico 1RESUMEN
Steroidogenic factor 1 (SF-1), an orphan nuclear receptor, regulates the enzymes that produce sex steroids, and disruption of the Ftz-F1 gene encoding SF-1 precludes adrenal and gonadal development. We now study the role of SF-1 at other levels of the hypothalamic/pituitary/gonadal axis. In Ftz-F1-disrupted mice, immunohistochemical analyses with antibodies against pituitary trophic hormones showed a selective loss of gonadotrope-specific markers, supporting the role of SF-1 in gonadotrope function. In situ hybridization analyses confirmed these results; pituitaries from Ftz-F1-disrupted mice lacked transcripts for three gonadotrope-specific markers (LH beta, FSH beta, and the receptor for gonadotropin-releasing hormone), whereas they exhibited decreased but detectable expression of the alpha-subunit of glycoprotein hormones. SF-1 transcripts in the developing mouse pituitary, which first became detectable at embryonic day 13.5-14.5, preceded the appearance of FSH beta and LH beta transcripts. In adult rat pituitary cells, SF-1 transcripts colocalized with immunoreactivity for the gonadotrope-specific LH. Finally, SF-1 interacted with a previously defined promoter element in the glycoprotein hormone alpha-subunit gene, providing a possible mechanism for the impaired gonadotropin expression in Ftz-F1-disrupted mice. These studies establish novel roles of this orphan nuclear receptor in reproductive function.
Asunto(s)
Proteínas de Unión al ADN/fisiología , Receptores Citoplasmáticos y Nucleares/fisiología , Reproducción/fisiología , Factores de Transcripción/fisiología , Animales , Secuencia de Bases , Biomarcadores , ADN/genética , Sondas de ADN/genética , Proteínas de Unión al ADN/genética , Femenino , Hormona Folículo Estimulante/genética , Factores de Transcripción Fushi Tarazu , Regulación del Desarrollo de la Expresión Génica , Proteínas de Homeodominio , Hormona Luteinizante/genética , Masculino , Ratones , Ratones Mutantes , Datos de Secuencia Molecular , Hipófisis/crecimiento & desarrollo , Hipófisis/metabolismo , ARN Mensajero/genética , ARN Mensajero/metabolismo , Ratas , Receptores Citoplasmáticos y Nucleares/genética , Reproducción/genética , Factor Esteroidogénico 1 , Factores de Transcripción/genéticaRESUMEN
The cholesterol side-chain cleavage cytochrome P450 (CYP11A; P450scc) gene is expressed in rat ovarian follicles in response to gonadotropins (FSH/LH) and cAMP. To identify functional regions within the rat P450scc promoter, 894 basepairs (bp) of 5'-flanking sequence and 5'-deletions (at -379, -101, -73, and -38 bp) were linked to the human GH reporter gene and transfected into cultured rat granulosa cells. cAMP inducibility of the rat promoter was localized to a region (between -73/-38 bp) that contains one of two AGGT/CC/TA motifs, designated SCC1 (-51/-43 bp) and SCC2 (-79/-71 bp), within the rat promoter. One of the nuclear proteins in granulosa cells that binds to SCC1 was identified as the orphan receptor, steroidogenic factor-1 (SF-1). In contrast, multiple protein-DNA complexes formed with SCC2, only one of which was clearly identified as SF-1. Nuclear extract binding was sequence specific; SCC1 bound SF-1 more strongly than did SCC2. Thus, the two AGGT/CC/TA motifs of the rat promoter appear to differ structurally and functionally. Furthermore, because the expression of SF-1 mRNA precedes hormonal/cAMP induction of P450scc mRNA and is not regulated in vitro by cAMP, the functional role of SF-1 in transcriptional regulation of the P450scc gene, including its induction by cAMP, is not entirely clear and is probably dependent on other factors and/or the modification (phosphorylation?) of SF-1.
Asunto(s)
Enzima de Desdoblamiento de la Cadena Lateral del Colesterol/genética , Proteínas de Unión al ADN/metabolismo , Células de la Granulosa/metabolismo , Regiones Promotoras Genéticas , Receptores Citoplasmáticos y Nucleares/metabolismo , Factores de Transcripción/metabolismo , Transcripción Genética , Animales , Secuencia de Bases , Células Cultivadas , Enzima de Desdoblamiento de la Cadena Lateral del Colesterol/metabolismo , Colforsina/farmacología , AMP Cíclico/fisiología , Proteínas de Unión al ADN/genética , Femenino , Factores de Transcripción Fushi Tarazu , Proteínas de Homeodominio , Datos de Secuencia Molecular , Proteínas Nucleares/metabolismo , ARN Mensajero/análisis , Ratas , Receptores Citoplasmáticos y Nucleares/genética , Factor Esteroidogénico 1 , Factores de Transcripción/genéticaRESUMEN
The cytochrome P450 steroid hydroxylases are coordinately regulated by steroidogenic factor 1 (SF-1), a protein expressed selectively in steroidogenic cells. Based on its expression in steroidogenic tissues and DNA-binding specificity, we isolated a putative SF-1 cDNA from an adrenocortical cDNA library. As evidence that this cDNA encodes SF-1, we now show that it is selectively expressed in steroidogenic cells, that an antiserum against its protein product specifically abolishes the SF-1-related gel-shift complex, and that its coexpression increases promoter activity of the 21-hydroxylase 5'-flanking region in transfection experiments. Sequence analyses of the SF-1 cDNA revealed that it is the mouse homolog of fushi tarazu factor I (FTZ-F1), a nuclear receptor that regulates the fushi tarazu homeobox gene in Drosophila. A second FTZ-F1 homolog, embryonal long terminal repeat-binding protein (ELP), was recently isolated from embryonal carcinoma cells. SF-1 and ELP cDNAs are virtually identical for 1017 base pairs, including putative DNA-binding domains, but diverge at their 5'- and 3'-ends. One genomic clone contained both SF-1- and ELP-specific sequences, confirming their origin from a single gene. Characterization of this gene defined shared exons encoding common regions and alternative promoters and 3'-exons leading to differences between the two FTZ-F1 transcripts. We used in situ hybridization with transcript-specific probes to study the ontogeny of SF-1 and ELP expression. ELP transcripts were not detected from embryonic day 8 to adult, consistent with its previous isolation from embryonal carcinoma cells and its postulated role in early embryonic development.(ABSTRACT TRUNCATED AT 250 WORDS)
Asunto(s)
Proteínas de Unión al ADN/genética , Regulación Enzimológica de la Expresión Génica/genética , Regulación Neoplásica de la Expresión Génica/genética , Receptores Citoplasmáticos y Nucleares/genética , Esteroide Hidroxilasas/genética , Factores de Transcripción/genética , Neoplasias de la Corteza Suprarrenal/genética , Neoplasias de la Corteza Suprarrenal/patología , Secuencia de Aminoácidos , Animales , Secuencia de Bases , Proteínas Portadoras/análisis , Proteínas Portadoras/genética , Proteínas Portadoras/fisiología , ADN de Neoplasias/análisis , ADN de Neoplasias/genética , Proteínas de Unión al ADN/análisis , Proteínas de Unión al ADN/fisiología , Exones , Factores de Transcripción Fushi Tarazu , Genes Reguladores/genética , Genes Reguladores/fisiología , Proteínas de Homeodominio , Hibridación in Situ , Ratones , Datos de Secuencia Molecular , Neoplasias Experimentales/genética , Neoplasias Experimentales/patología , Regiones Promotoras Genéticas/genética , Receptores Citoplasmáticos y Nucleares/análisis , Receptores Citoplasmáticos y Nucleares/fisiología , Proteínas Represoras/análisis , Proteínas Represoras/genética , Proteínas Represoras/fisiología , Esteroide 21-Hidroxilasa/genética , Factor Esteroidogénico 1 , Factores de Transcripción/análisis , Factores de Transcripción/fisiología , Transcripción Genética/genética , Células Tumorales CultivadasRESUMEN
In a concerted analysis of the genes encoding three mouse steroid hydroxylases, we identified and characterized a transcriptional regulatory protein, designated steroidogenic factor 1 (SF-1), that contributes to the coordinate expression in adrenocortical cells. SF-1, an orphan member of the nuclear receptor family, binds to PyCAAGGPyCPu motifs upstream of the steroid hydroxylases to regulate their expression. In the present study, we extend these findings by examining the role of SF-1 in regulation of the rat P450 aromatase gene in gonadal tissues. The 5'-flanking region of the rat aromatase gene was isolated by a polymerase chain reaction-based approach, using primers corresponding to the 5'- and 3'-ends of a published aromatase sequence. DNA sequence analysis revealed three differences between our sequence and the previously published sequence, including a 44-base pair (bp) insertion. Moreover, the transcription initiation site, as determined by primer extension analysis, differed from that previously proposed. The new transcription initiation site is located 23 bp 3' of a putative TATA box. When a revised rat sequence was compared to that of the human aromatase PII promoter by BEST-FIT analysis, a region of about 300 bp was identified that was 80% conserved between the two promoters. A potential SF-1 site, CCAAGGTCA, was identified at position -82 within this region. An oligonucleotide probe containing this putative SF-1 site was used in gel mobility shift assays. Consistent with previous studies, a specific complex was observed with nuclear extracts from gonadal steroidogenic tissues but was absent with nuclear extracts from nonsteroidogenic tissues. The role of SF-1 in this steroidogenic cell-specific complex was next addressed more directly. Bacterial extracts containing an SF-1-glutathione S-transferase fusion protein interacted specifically with the putative SF-1 site, and polyclonal antisera against SF-1-glutathione S-transferase specifically abolished the complex formed with nuclear extracts from rat ovaries or R2C rat Leydig tumor cells. Finally, the aromatase SF-1 element increased expression of an SV40 promoter/luciferase construct in transient transfection experiments in a steroidogenic cell-selective manner. Collectively, these studies implicate SF-1 in the regulation of steroid hydroxylase gene expression in nonadrenal tissues, significantly extending previous studies in adrenocortical cells.
Asunto(s)
Aromatasa/genética , Núcleo Celular/química , Proteínas de Unión al ADN/metabolismo , Regulación de la Expresión Génica/efectos de los fármacos , Receptores de Superficie Celular/metabolismo , Factores de Transcripción/metabolismo , Secuencia de Aminoácidos , Animales , Secuencia de Bases , Línea Celular , ADN/química , Sondas de ADN , Proteínas de Unión al ADN/química , Proteínas de Unión al ADN/genética , Factores de Transcripción Fushi Tarazu , Células HeLa , Proteínas de Homeodominio , Humanos , Ratones , Datos de Secuencia Molecular , Reacción en Cadena de la Polimerasa , Regiones Promotoras Genéticas , Ratas , Receptores de Superficie Celular/química , Receptores de Superficie Celular/genética , Receptores Citoplasmáticos y Nucleares , Proteínas Recombinantes , Secuencias Reguladoras de Ácidos Nucleicos , Factor Esteroidogénico 1 , Factores de Transcripción/química , Factores de Transcripción/genética , TransfecciónRESUMEN
Cultured bovine adrenocortical cells reach replicative senescence after 100-120 population doublings in culture. Before reaching senescence, cells undergo high frequency phenotypic switching from CYP17+ to CYP17-, where '+' and '-' refer to the ability of intracellular cyclic AMP to induce expression of CYP17 (steroid 17 alpha-hydroxylase). We used luciferase reporter constructs to assess the activity of the CYP17 promoter in bovine adrenocortical cells before and after phenotypic switching. We constructed two plasmids containing -2544 to +29 and -488 to +29 of the 5' region of CYP17 linked to a promoterless luciferase gene. Because of technical difficulties with transient transfection of late-passage bovine adrenocortical cells, these experiments were performed using stable transfection. Cells at early passage (PDL 10) and late passage (PDL 55) were cotransfected with either of these two plasmids ligated to pSV3neo, and G418-resistant pools of clones were derived. The activity of the CYP17 promoter in these transfectants was tested by growing cells in complete medium until semiconfluent and then transferring them into defined medium with cholera toxin and insulin-like growth factor I for 6 h. Luciferase activity was consistently induced by cholera toxin/IGF-I over five passages in pooled clones derived by transfection of early passage cells with the -488 construct. Despite the lack of expression of the endogenous CYP17 gene in transfectants from late-passage cells, induced luciferase activity was higher in late-passage transfectants than early-passage transfectants for both the -2544 and -488 constructs.(ABSTRACT TRUNCATED AT 250 WORDS)